No profile data available.
VitaSpring Biomedical Co. Ltd. (VSBC) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Riverside, United States.
It reported revenue of $0 for fiscal year 2024, and net income of -$1.12 million. In Q3 2023 (the quarter ended October 31, 2022) revenue was $0, down 100.0% from a year before. Its market capitalization was $6.58 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended January 31, 2024; market data as of October 8, 2026.
VitaSpring Biomedical Co. , a development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products. It focuses on the development of cell-based medical technologies for use in regenerative medicine, preventive health care, beauty, and anti-aging applications.
VitaSpring Biomedical reported $0 in revenue for fiscal year 2024. In Q3 2023 revenue was $0.
$6.58 million as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Longeveron Inc. (LGVN), Can-Fite BioPharma Ltd. (CANF), OSR Holdings, Inc. (OSRH), America Great Health (AAGH).